Compare GLP & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLP | INSP |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2005 | 2018 |
| Metric | GLP | INSP |
|---|---|---|
| Price | $52.59 | $63.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 16 |
| Target Price | $46.00 | ★ $94.00 |
| AVG Volume (30 Days) | 65.4K | ★ 556.8K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | ★ 6.40% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $18,561,421,000.00 | $82,050,000.00 |
| Revenue This Year | $64.13 | $8.02 |
| Revenue Next Year | $11.74 | $8.11 |
| P/E Ratio | $23.28 | ★ N/A |
| Revenue Growth | 8.14 | ★ 62.18 |
| 52 Week Low | $39.58 | $38.91 |
| 52 Week High | $53.00 | $147.03 |
| Indicator | GLP | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 68.92 | 64.31 |
| Support Level | $46.01 | $56.50 |
| Resistance Level | N/A | $66.21 |
| Average True Range (ATR) | 0.92 | 2.37 |
| MACD | 0.12 | -0.10 |
| Stochastic Oscillator | 94.67 | 92.52 |
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.